Clovis Oncology (CLVS) Tops Q3 EPS by 25c
Tweet
Share
E-mail
Get Alerts CLVS Hot Sheet
Join SI Premium – FREE
Clovis Oncology (NASDAQ: CLVS) reported Q3 EPS of ($1.70), $0.25 better than the analyst estimate of ($1.95).
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Ross Stores raises 2026 outlook after strong second-quarter results
- ScanSource (SCSC) Tops Q4 EPS by 32c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
